Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/23/2005 | EP1596827A2 Use of pvp-iodine liposomes for treatment of herpes |
11/23/2005 | EP1596826A1 Use of pvp-iodine liposomes for treatment of atopic dermatitis |
11/23/2005 | EP1596825A2 Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs |
11/23/2005 | EP1596824A1 Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem |
11/23/2005 | EP1596823A2 A stable ophthalmic composition |
11/23/2005 | EP1596822A2 A low dose corticosteroid composition |
11/23/2005 | EP1596821A2 Synergistic compositions and methods for potentiating anti-oxidative activity |
11/23/2005 | EP1596812A2 Bioadhesive liquid composition which is substantially free of water |
11/23/2005 | EP1596767A2 Random and non-random alkylene oxide polymer alloy compositions |
11/23/2005 | EP1596756A2 Absorption enhancing agents |
11/23/2005 | EP1467718B1 Method of treatment of a patient requiring analgesia |
11/23/2005 | EP1408968B1 Receptor-adapted nicotine withdrawal by a combination of atropine, scopolamine, clonidine |
11/23/2005 | EP1377227B1 Vessel sealing instrument |
11/23/2005 | EP1372645B1 Reconstitutable parenteral composition containing a cox-2 inhibitor |
11/23/2005 | EP1328306B1 Material for producing products having fibrinolytic and/or antibacterial properties |
11/23/2005 | EP1282430B1 Lipids for stimulation of immune response |
11/23/2005 | EP1276497B1 Mixture of defibrotide and g-csf and its use for activating haematopoietic progenitors |
11/23/2005 | EP1267846B1 Transdermal therapeutic system for the delivery of lerisetron |
11/23/2005 | EP1263802B1 Hydrogel biomedical articles |
11/23/2005 | EP1258249B1 Oral preparations for diabetes |
11/23/2005 | EP1194161B1 Stable factor viii compositions |
11/23/2005 | EP1162948B1 An improved reversible contraceptive for male and female |
11/23/2005 | EP1140028B1 Biodegradable poly(phosphoester) compositions for treating ovarian cancer |
11/23/2005 | EP1137401B1 Administration of neurotrophic agents to the central nervous system |
11/23/2005 | EP1133555B1 Pharmaceutical factor vii preparation |
11/23/2005 | EP1117385B1 Aqueous enteric coating composition with low gastric permeability |
11/23/2005 | EP1117383B1 Dosage form comprising therapeutic formulation |
11/23/2005 | EP1089739B1 Cyclophosphamide coated tablets |
11/23/2005 | EP1082102B1 Biologically active composition |
11/23/2005 | EP1058547B1 Pharmaceutical compositions containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
11/23/2005 | EP1041973B1 Microcapsules; process for preparing microcapsules containing a biologically active compound and liquid solution |
11/23/2005 | EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition |
11/23/2005 | EP0925293B1 Method of producing an extruded nutritional supplement product |
11/23/2005 | EP0906088B1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
11/23/2005 | EP0781344B1 Novel implant and novel vector for the treatment of acquired diseases |
11/23/2005 | EP0732934B1 Long-acting injection suspensions of an lhrh analogue and a process for their preparation |
11/23/2005 | CN2741569Y Antiseptic biological film for uterine neck |
11/23/2005 | CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
11/23/2005 | CN1700927A Pharmaceutical composition for treating menorrhagia and method for preparing the same |
11/23/2005 | CN1700914A The prevention and treatment for inflammatory disease in oral-cavity mucosa |
11/23/2005 | CN1700913A Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
11/23/2005 | CN1700912A Choline ascorbate formulations |
11/23/2005 | CN1700910A Controlled release tablets of metformin |
11/23/2005 | CN1700909A Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
11/23/2005 | CN1700908A Improved release dosage form comprising two cores |
11/23/2005 | CN1700907A Improved release dosage form comprising two cores and an opening therein |
11/23/2005 | CN1700906A Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs |
11/23/2005 | CN1700859A Nodulisporic acid derivative spot-on formulations for combating parasites |
11/23/2005 | CN1699346A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
11/23/2005 | CN1698834A Chinese medicinal capsule for treating apoplexy and its preparation method |
11/23/2005 | CN1698648A Montmorillonite dispersed tablet and preparation technique thereof |
11/23/2005 | CN1698585A Prosoma liposome preparation, its production method and using method |
11/23/2005 | CN1698584A Nose nebulizing gelling agent containing active component |
11/23/2005 | CN1698583A Near-infrared fluorescent magnetic micro-emulsion nanometer particle, its preparation method and application |
11/23/2005 | CN1698582A Silicon coated near-infrared fluorescent magnetic nanometer particle, its preparation method and applicaiton |
11/23/2005 | CN1698581A Carrying suppository for cavity/canal drug administration |
11/23/2005 | CN1698580A Sustained release formulations for parenteral administration and process of preparation |
11/23/2005 | CN1228371C Preparation method and uses of carboxymethyl chitosan and sodium alginate blended microcapsule |
11/23/2005 | CN1228343C Substance having steroid-like structure, process for production thereof and antitumor agents containing same |
11/23/2005 | CN1228087C Medicinal preparation and its prepn. and application |
11/23/2005 | CN1228082C Method for preparing pharmaceutics of hydrolysate of brain protein |
11/23/2005 | CN1228081C Combination of medicinal preparation of having antivirus function |
11/23/2005 | CN1228079C Oral medicine for treating child restless syndrome |
11/23/2005 | CN1228076C Chinese traditional medicine for treating preceded menstrual cycle and excessive menses due to blood heat |
11/23/2005 | CN1228075C Anti-senescence Chinese traditional medicine |
11/23/2005 | CN1228074C Chinese traditional medicine for treating immune hypofunction and disfunction |
11/23/2005 | CN1228073C Semen coicis-poria cocos capsule for stomachache |
11/23/2005 | CN1228060C American ginseng buccal tablet and its preparation method |
11/23/2005 | CN1228049C Slow releasing micropill containing active component of indapamide and method for preparing the same |
11/23/2005 | CN1228048C Medicine composition containing alpha-pinene and 1,8-eucalyptol fever-tree oil and use thereof |
11/23/2005 | CN1228047C Remedies for heratoconjunctival diseases containing farnesyl acetate as the active ingredient |
11/23/2005 | CN1228046C Fluctin slow release tablet |
11/23/2005 | CN1228045C Fast collapsed and fast dissolved preparation for oral cavity and producing method |
11/23/2005 | CN1228044C Water-soluble medicine particle-type slow-release composition, preparation and its preparing method |
11/23/2005 | CN1228043C Sustained release groundmass for highly soluble drugs |
11/23/2005 | CN1228042C Asiaticoside liposome and its use |
11/23/2005 | CN1228041C Methods for preparation of lipid-encapsulated therapeutic agents |
11/22/2005 | US6967218 Pravastatin pharmaceutical formulations and methods of their use |
11/22/2005 | US6967106 Purification; removal by-products; side effect reduction |
11/22/2005 | US6967089 Delivery system for porcine somatotropin |
11/22/2005 | US6967032 Product |
11/22/2005 | US6967028 Solvent-free; coating and stirring in soluble supercritical fluid |
11/22/2005 | US6967026 Hard capsule filled with drug and polyethylene glycol |
11/22/2005 | US6967025 A disposable product comprising an absorbent core containing atleast a spore which has the ability to germinate into a microorganism which is antagonist of undesirable strains of microorgansims |
11/22/2005 | US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces |
11/22/2005 | US6967020 Oxygen carrier system, artificial oxygen carrier, and reducing agent |
11/22/2005 | US6967017 preservative-free mixture of water and propylene glycol; pH of 3.5 to 5.0 achieved by the addition of a concentrated strong acid; can be nebulised with currently available nebulisers |
11/22/2005 | US6966467 Valve for aerosol container |
11/22/2005 | CA2378894C Taste masking of oral quinolone liquid preparations using ion exchange resins |
11/22/2005 | CA2304722C Acidic addition salts of morphine alkaloids and the application thereof |
11/22/2005 | CA2272586C Rapidly disintegrable pharmaceutical composition |
11/22/2005 | CA2260845C Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium |
11/22/2005 | CA2258918C Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
11/22/2005 | CA2249336C Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
11/22/2005 | CA2244767C Process for the production of powdered pulmonary surfactant preparations |
11/22/2005 | CA2161683C Veterinary composition containing a proton pump inhibitor |
11/22/2005 | CA2154164C Excipient stabilization of polypeptides treated with organic solvents |
11/22/2005 | CA2153348C Enteral diet and method for providing nutrition to a diabetic |
11/22/2005 | CA2109697C Oral-administration forms of a medicament containing pantoprazole |
11/22/2005 | CA2080353C Unimolecular micelles and method of making the same |